<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04763291</url>
  </required_header>
  <id_info>
    <org_study_id>33-055 ex 20/21</org_study_id>
    <nct_id>NCT04763291</nct_id>
  </id_info>
  <brief_title>Cardiovascular and InflammAging Study</brief_title>
  <official_title>Effects of Long-term Consumption of Two Plant-based Dietary Supplements on Cardiovascular Health and Low-grade Inflammation in the Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Green Beat</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Green Beat</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evidence from previous studies supports a strong relationship between fruit and vegetable&#xD;
      consumption and reduced cardiac risk. This could be mediated via improvements on blood&#xD;
      pressure, platelet function and vascular reactivity. Certain vitamins and polyphenols found&#xD;
      in fruits and vegetables, have antioxidant and anti-inflammatory effects and play a major&#xD;
      role on the function of immune cells. Previous studies have also demonstrated the importance&#xD;
      of omega-3 fatty acids on humans' health and their positive effects on the cardiovascular&#xD;
      system and blood lipids regulation, as well as their involvement on inflammatory response.&#xD;
      Nutritional regimens with adequate intake of micronutrients, fruit and vegetables, omega-3&#xD;
      fatty acids, low in sugar and saturated fats, such as the Mediterranean diet or vegetarian&#xD;
      diets, can reduce chronic inflammation and oxidative stress and improve cardiovascular risk&#xD;
      profile. Considering that the population's fruit and vegetable and omega-3 intakes are below&#xD;
      recommendations, whole food-based supplements could provide an accessible form of&#xD;
      supplementation to bridge the gap between actual and recommended intakes. This study is&#xD;
      aiming to assess whether long-term separate ingestions of an encapsulated juice powder&#xD;
      concentrate and a plant-based omega fatty acid supplement, or a combined ingestion of the&#xD;
      two, can affect biomarkers of cardiovascular health, low-grade inflammation and indicators of&#xD;
      biological aging in older adults.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lipid profile markers</measure>
    <time_frame>24 months</time_frame>
    <description>Total cholesterol, HDL, LDL, ApoA1, triglycerides, Omega-3-Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemostasis markers</measure>
    <time_frame>24 months</time_frame>
    <description>Platelet aggregation, thrombelastometry, coagulation (Quick, PT, PTT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative stress markers</measure>
    <time_frame>24 months</time_frame>
    <description>oxLDL, MDA, carbonyl proteins, (CP), redox state of albumin, homocysteine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>24 months</time_frame>
    <description>Glucose, insulin, HOMA-IR, HbA1c</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration changes in cytokines/ cytokine receptors</measure>
    <time_frame>24 months</time_frame>
    <description>TNF-α, sTNFR1 and sTNFR2, CCL5 = RANTES, IL-1β, hsCRP, CCL2 = MCP-1, Osteoprotegerin (OPG), IL-5, IL-8</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vitamin K metabolism</measure>
    <time_frame>24 months</time_frame>
    <description>Osteocalcin, matrix Gla protein (MGP), vitamins K1 and K2 (MK-7)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Leukocytes' relative telomere length (RTL)</measure>
    <time_frame>24 months</time_frame>
    <description>Genomic DNA will be isolated using an automated system for nucleic isolation. RTL will be measured by a qPCR assay which quantifies the ratio of average telomere length to a single-gene copy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper respiratory tract symptoms</measure>
    <time_frame>24 months</time_frame>
    <description>The number of symptoms experienced and severity of symptoms will be assessed by the Wisconsin upper respiratory symptoms survey (WURSS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>24 months</time_frame>
    <description>Assessed through the Short Form Survey (SF-36), which consists of 8 scales, namely: physical functioning, physical role functioning, bodily pain, general health, vitality, social functioning, emotional role functioning, mental health. All items are scored on a scale from 0 to 100 and higher scores denote a more favourable health state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>24 months</time_frame>
    <description>Cognitive function will be assessed by the CFD-index, which takes into account the following 5 dimensions: Attention (alertness, shared attention, processing speed), Verbal long-term memory, Executive functions (spatial working-memory, cognitive flexibility), Expressive language (word-fluency, object designation), Perceptual-motoric functions (visuoconstruction).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Plasma concentrations of vitamins and carotenoids</measure>
    <time_frame>24 months</time_frame>
    <description>Retinol, vitamins C, D, E (α-toc and γ-toc), α-carotene, β-carotene, lutein, zeaxanthin, lycopene, β-cryptoxanthin</description>
  </other_outcome>
  <other_outcome>
    <measure>Plasma concentrations of fatty acids</measure>
    <time_frame>24 months</time_frame>
    <description>Docosahexaenoic acid, docosapentaenoic acid, eicosapentaenoic acid, arachidonic acid, alphalinolenic acid, linoleic acid, oleic acid, palmitoleic acid, stearic acid.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Aging</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Overweight or Obesity</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Continue habitual diet and lifestyle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fruit, Vegetable and Berry (FVB) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants have to ingest an encapsulated juice powder concentrate, otherwise continue their habitual diet and lifestyle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omega group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants have to ingest a plant-based fatty acid supplement, otherwise continue their habitual diet and lifestyle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fruit, Vegetable, Berry and Omega (FVBO) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants have to ingest an encapsulated juice powder concentrate along with a plant-based fatty acid supplement, otherwise continue their habitual diet and lifestyle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Juice Plus+ Fruit, Vegetable and Berry blends</intervention_name>
    <description>Encapsulated juice powder concentrate derived from 36 dried fruits, vegetables and berries.</description>
    <arm_group_label>Fruit, Vegetable and Berry (FVB) group</arm_group_label>
    <arm_group_label>Fruit, Vegetable, Berry and Omega (FVBO) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Juice Plus+ Omega blend</intervention_name>
    <description>Encapsulated plant-based fatty acid supplement.</description>
    <arm_group_label>Fruit, Vegetable, Berry and Omega (FVBO) group</arm_group_label>
    <arm_group_label>Omega group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Post menopausal&#xD;
&#xD;
          -  Non-smokers&#xD;
&#xD;
          -  BMI 25 to 35 kg/m2&#xD;
&#xD;
          -  Vegetable intake ≤ 2 servings/ day&#xD;
&#xD;
          -  Intake of fruits ≤ 2 servings /day&#xD;
&#xD;
          -  Adherence to a 6-week washout period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;60 and &gt;80 years&#xD;
&#xD;
          -  Smokers (or ex-smokers who quit smoking less than 3 years ago)&#xD;
&#xD;
          -  Aversion to stop the intake of nutritional supplements and food, that could interfere&#xD;
             with the study outcome&#xD;
&#xD;
          -  Subjects with histamine intolerance&#xD;
&#xD;
          -  Hypertension, starting with grade 2 according to the classification of the European&#xD;
             Society of Hypertension: systolic blood pressure &gt; 160mmHg, diastolic blood pressure&#xD;
             &gt;100 mmHg&#xD;
&#xD;
          -  Medication: any anti-inflammatory medication and medication with relevant antioxidant&#xD;
             properties, psychotropic drugs, immunosuppressives, cytostatics, anticoagulants,&#xD;
             contraceptives, diuretics, pain medication&#xD;
&#xD;
          -  Clinically relevant infectious diseases&#xD;
&#xD;
          -  Diabetes mellitus type I and type II&#xD;
&#xD;
          -  Auto-immune diseases&#xD;
&#xD;
          -  Any stents and coronary artery diseases (CAD)&#xD;
&#xD;
          -  Cancer patients&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Significant lifestyle changes, e.g. changes in diet or physical activity profile&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manfred Lamprecht, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Green Beat</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manfred Lamprecht, PhD</last_name>
    <phone>+43 664 1328287</phone>
    <email>manfred.lamprecht@greenbeat.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Green Beat</name>
      <address>
        <city>Graz</city>
        <zip>8042</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Lamprecht, Prof</last_name>
      <phone>+43 664 1328287</phone>
      <email>manfred.lamprecht@greenbeat.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Otto Loewi Research Center, Section of Physiological Chemistry, Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gerhard Cvirn, PhD</last_name>
      <phone>+43 316 385 72122</phone>
      <email>mailto:gerhard.cvirn@medunigraz.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 2, 2021</study_first_submitted>
  <study_first_submitted_qc>February 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Green Beat</investigator_affiliation>
    <investigator_full_name>Lamprecht Manfred PhD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Aging</keyword>
  <keyword>CVD prevention</keyword>
  <keyword>Low-grade inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

